32 results
8-K
EX-99.1
NMTC
NeuroOne Medical Technologies Corp
14 May 24
NeuroOne® Reports Second Quarter Fiscal Year 2024 Financial Results and Provides Corporate Update
4:10pm
Ablation System:
Completed site training and initiated limited commercial launch of the OneRF™ Ablation System in late March
Successfully implanted five
8-K
EX-99.1
NMTC
NeuroOne Medical Technologies Corp
15 Mar 24
Submission of Matters to a Vote of Security Holders
4:30pm
direct responsibility for international commercial expansion, including Sales, Training & Education, Marketing, Business Development and Program
8-K
EX-99.1
NMTC
NeuroOne Medical Technologies Corp
13 Feb 24
NeuroOne® Reports First Quarter Fiscal Year 2024 Financial Results and Provides Corporate Update
4:15pm
Society (AES) in December 2023
Completed full sales force training for Zimmer Biomet personnel in January 2024
OneRF™ Ablation System:
Received FDA
8-K
EX-99.1
uqoq1 f4iv
14 Dec 23
NeuroOne® Reports Fiscal Fourth Quarter and Full Fiscal Year 2023 Financial Results and Provides Corporate Update
4:30pm
8-K
2eek8p5aqh45h
14 Nov 23
Volker strengthens existing management team in areas of commercialization, business development, and reimbursement
5:28pm
8-K
EX-99.1
abbkml70b7u0b
14 Aug 23
NeuroOne® Reports Third Quarter Fiscal Year 2023 Financial Results and Provides Corporate Update
4:15pm
424B5
jdygq oldyyh
26 Jul 23
Prospectus supplement for primary offering
4:24pm
424B5
5uxm bxrmacn18nsf
24 Jul 23
Prospectus supplement for primary offering
4:43pm
8-K
EX-99.1
dc0z mz6cnjuc
11 May 23
NeuroOne® Reports Second Quarter Fiscal Year 2023 Financial Results and Provides Corporate Update
4:16pm
8-K
EX-10.1
x8gupm420s3 0mkl
7 Jan 21
NeuroOne Medical Technologies Corporation Appoints Ronald McClurg, Experienced Financial Industry Executive, as Chief Financial Officer
8:59am
8-K
EX-10.1
sxo4ugfkmczgz cw
22 Jul 20
Entry into a Material Definitive Agreement
8:13am